Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia
about
The emerging roles of exosomes in leukemogeneisMechanisms of Nuclear Export in Cancer and Resistance to ChemotherapyA hostel for the hostile: the bone marrow niche in hematologic neoplasmsNuclear transport of galectin-3 and its therapeutic implicationsGalectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinomaPyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells.Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasmsDysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosis.Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasiaCombination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and GalactomannansBone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop.The hematopoietic stem cell niche--home for friend and foe?Extracellular galectin-3 in tumor progression and metastasis.Galectin-3 inhibitors: a patent review (2008-present).Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.Myeloid malignancies and the microenvironment.FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors.The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells.Oroxyloside A Overcomes Bone Marrow Microenvironment-Mediated Chronic Myelogenous Leukemia Resistance to Imatinib via Suppressing Hedgehog Pathway.Modeling the influence of stromal microenvironment in the selection of ENU-induced BCR-ABL1 mutants by tyrosine kinase inhibitors.Expression profiling of cancer-related galectins in acute myeloid leukemia.Galectin-3 in pre-B acute lymphoblastic leukemia.Molecular pathways: involving microenvironment damage responses in cancer therapy resistance.Role of Galectins in Multiple Myeloma.Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens.Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion.[Chronic myeloid leukemia stem cells: cross-talk with the niche].Clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.Multiple Roles of Glycans in Hematological MalignanciesExtracellular galectins as controllers of cytokines in hematological cancer
P2860
Q26748606-3F702129-92AA-4327-A7AC-67602263D203Q26764837-57D0D2DB-7C0C-40B7-B5EC-41BFF384EBE6Q26777629-D92F58AC-6537-4415-8D08-013CD3556D29Q26824889-F6EF21F7-CA69-422E-8E95-470EB02AB207Q28535429-42D3B085-0F4B-4E38-BB23-C936F7E69EFDQ30361951-14C96EEA-FD68-45CA-89BE-AAF0211DBB27Q31077729-8D44427A-E761-44C5-BDE8-7DAF723CB9D8Q33799623-520E93FC-E080-439E-9199-E4C718CF1A31Q35096615-E97731AC-A4E1-4550-95D5-AAD612D5063AQ36062042-E68343AE-DB91-4208-A9A6-9CFBA5FB3D2CQ36642752-E373B4A7-6747-4ED7-87EA-F6A2275ABD7CQ37065931-94C0ADB6-F7E3-4690-92CC-822B6818F614Q37094051-9EDA281B-F2DD-4317-B5F2-6110CC5E5A14Q37264244-34DABD65-625C-4E98-93B7-8D23B8DCDF31Q38057413-2A006CC1-F7D9-4451-B675-F1E7B2CE3BB5Q38071041-770A3518-03C8-42A9-B7B6-90E394D1BD37Q38225141-0CFFC787-4BDD-480D-B932-D12E379D3222Q38238525-BD858D38-EB9F-47AF-A333-24F5304FC13BQ38269046-89B0C8C6-F045-4AF6-A306-CA7ABFDD701FQ39073878-89552F0B-DA81-41BC-9C51-78CA3DA0F970Q39126141-EA2E8A11-C192-4465-A30D-B2C91F02E144Q39475895-DE65A781-F24A-4710-B242-68FC6E40EBA2Q41370892-AD15213D-C833-4008-8DBC-B2256BDBD956Q41575103-3895FB3A-9E3B-45B1-9DFB-C7FB0DA0521AQ41753912-8E603577-A310-4B66-93A3-E297C0DC3903Q41891815-FAAFF2AB-7F52-4755-AC31-02910502FF8AQ42006859-AA6BF4F3-5979-4693-A9CC-50B5C52B2E95Q47282400-88C02B7F-D565-4ECE-A913-A81283B8BAC7Q47783708-7EB28C9C-1CA3-49FA-A2B6-F3A7861994F8Q51122167-DB4F008B-231D-42E4-AE70-8463E2C1CFC3Q52312098-6CE3A814-BD68-4D93-9263-230F6463E10AQ54354799-A53F391C-194C-437E-B795-409471C863C7Q54697325-FD09C2D1-F6DE-4259-9B3E-D288F35FF390Q58761454-240F2DAF-5749-499C-9682-A04CD54A5982Q58803547-B5CB98D5-321B-4136-9918-A2B9EAD34E59
P2860
Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@ast
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@en
type
label
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@ast
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@en
prefLabel
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@ast
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@en
P2093
P2860
P356
P1476
Galectin-3 (Gal-3) induced by ...... n chronic myelogenous leukemia
@en
P2093
Eishi Ashihara
Hisao Nagoshi
Junya Kuroda
Kenichi Akaji
Masafumi Taniwaki
Miki Kiyota
Mio Yamamoto-Sugitani
Nana Sasaki
Nobuhiko Uoshima
Ryuko Nakayama
P2860
P304
17468-17473
P356
10.1073/PNAS.1111138108
P407
P577
2011-10-10T00:00:00Z